FDA Approves Combination Pegloticase and Methotrexate for Gout
Pegloticase plus methotrexate has been approved as a treatment for refractory gout.
Source: medscape.com
Stay updated with breaking news from John Botson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pegloticase plus methotrexate has been approved as a treatment for refractory gout.
-- Oral presentation on KRYSTEXXA (pegloticase injection) plus methotrexate to be held June 2, 2022 at 11:35 a.m. CEST-- -- Additional data presentations provide new insights on psychosocial and